Tecan uses cookies to improve our website. By continuing to browse our website, you accept our cookie policy.

This content is available also in other languages

x

This content is available also in other languages

September 12, 2006 | Corporate News | English

Tecan presents at the 2006 UBS Global Life Sciences Conference

Zurich, Switzerland, September 12, 2006 - Tecan announced that it will present at the 2006 UBS Global Life Sciences Conference on Monday, September 25, 2006 at 11:30 a.m. (EDT) at the Grand Hyatt New York, New York, NY.

Thomas Bachmann, Chief Executive Officer of Tecan, will give an overview of Tecan and discuss its market and expectations for the future.

Mr. Bachmann’s presentation will also be relayed by live audio web cast which interested parties may access via Tecan’s corporate home page at www.tecan.com. A link to the web cast will be provided immediately prior to the event. An audio archive of the presentation will remain available on the company’s website until October 28, 2006.

 

About Tecan

Tecan (www.tecan.com) is a leading global player in the Life Sciences supply industry specializing in the development, production, and distribution of advanced automation solutions enabling pharma and academic research, diagnostics, food and veterinary research as well as forensics. Through its REMP subsidiary (www.remp.com), Tecan is the leading supplier of compound and sample storage, management and logistics solutions. Tecan clients are pharmaceutical and biotechnology companies, university research departments and diagnostic laboratories. Founded in Switzerland in 1980, the company has manufacturing, research and development sites in both North America and Europe and maintains a sales and service network in 52 countries. In 2005, Tecan achieved sales of CHF 344.9 million (USD 275.9 Mio.; EUR 222.5 Mio.). Registered shares of Tecan Group are traded on the SWX Swiss Exchange (TK: TECN/Reuters: TECZn.S/Valor 1210019).

For further information please contact:

Christopher Hanan
Head of Corporate & Business Development

T +41 44 922 83 15
investor@tecan.com
www.tecan.com